Patents by Inventor Jeffrey H. Burbank

Jeffrey H. Burbank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130281799
    Abstract: One of the most significant safety concerns in the automation of extracorporeal blood treatments such as dialysis is the risk of blood leakage. Extracorporeal blood treatment systems draw blood at such a high rate that a loss of integrity in the blood circuit can be serious. There are a number of mechanisms for detecting and preventing leaks, but none is perfect. This tends to limit the use of such equipment in unsupervised settings, such as the home will be limited. Some leak detection schemes can be made sensitive enough to detect the barest of leaks, but when this is done, they result in too many false positives. The invention combines information from multiple inputs to enhance sensitivity in leak detection and reduce the problem of false positives.
    Type: Application
    Filed: June 18, 2013
    Publication date: October 24, 2013
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER
  • Publication number: 20130264250
    Abstract: A first connector of a connector assembly of a sterile batch container can be unsealed. The connector assembly can be attached to a filling port of the sterile batch container and can have a sterile filter arranged between the filling port and the first connector. The first connector can be coupled so as to receive produced purified water. A transmembrane pressure can be monitored across the sterile filter while flowing the purified water through the connector assembly into the sterile batch container so as to provide a sterile fluid stored therein. The connector assembly can be detached from the filling port of the sterile batch container. After the detaching, the sterile batch container can be coupled to the blood treatment system. In response to a change in the transmembrane pressure exceeding a predefined level, an alarm signal can be generated.
    Type: Application
    Filed: June 4, 2013
    Publication date: October 10, 2013
    Inventors: James M. BRUGGER, Jeffrey H. BURBANK, Brian C. GREEN
  • Patent number: 8545428
    Abstract: Systems, methods, and devices for preparation of water for various uses including blood treatment are described. In embodiments, fluid is passed either by pump or passively by gravity feed, through various filtration elements from a fluid source to a treatment fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment which provides multiple benefits and liabilities to overcome, as discussed herein. Mechanisms for preparing pure water for infusion or medicaments are described such as elimination of chlorine and colloidal aluminum. Also various control mechanisms to help avoid contamination are describe.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: October 1, 2013
    Assignee: Nxstage Medical, Inc.
    Inventors: Jeffrey H. Burbank, Brian C. Green, Dennis M. Treu, Christopher S. McDowell, Goetz Friederichs
  • Publication number: 20130228505
    Abstract: Systems, methods, and devices for preparation of purified water and medicaments for various uses including blood treatment are described. Methods, devices, and systems for creating multiple-treatment batches are described. For example, a medicament fluid circuit can include a container with an interior chamber. The container can have a fluid filling port and a fluid extraction port. Both ports can be connected to the interior chamber. The filling port can have two sterilizing filters, each of which has a membrane. The sterilizing filters can be connected in series the membranes are separated by a distance of at least 0.5 cm. A first of the sterilizing filters can have a sealed inlet. The fluid extraction port can be sealed.
    Type: Application
    Filed: April 11, 2013
    Publication date: September 5, 2013
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER
  • Publication number: 20130199722
    Abstract: The disclosed subject matter includes a structure and method for making a dual-lumen needle from single lumen needles to take advantage of the much higher economies of scale. Variations include two needles joined by a flow junction and one needle and a single cannula joined by a flow junction. In addition disclosed are methods of using a dual-lumen needle in a two needle access for blood treatment is disclosed in which at least venous flow is provided through a dual-lumen needle with arterial flow just sufficient to provide air infiltration detection in the event of withdrawal of the dual-lumen needle.
    Type: Application
    Filed: October 25, 2011
    Publication date: August 8, 2013
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. Burbank, Jamea M. Brugger, Joseph E. Turk
  • Patent number: 8469331
    Abstract: Systems, methods, and devices for preparation of purified water and medicaments for various uses including blood treatment are described. Methods, devices, and systems for creating multiple-treatment batches are described.
    Type: Grant
    Filed: April 9, 2007
    Date of Patent: June 25, 2013
    Assignee: NxStage Medical, Inc.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Patent number: 8460558
    Abstract: A first connector of a connector assembly of a sterile batch container can be unsealed. The connector assembly can be attached to a filling port of the sterile batch container and can have a sterile filter arranged between the filling port and the first connector. The first connector can be coupled so as to receive produced purified water. A transmembrane pressure can be monitored across the sterile filter while flowing the purified water through the connector assembly into the sterile batch container so as to provide a sterile fluid stored therein. The connector assembly can be detached from the filling port of the sterile batch container. After the detaching, the sterile batch container can be coupled to the blood treatment system. In response to a change in the transmembrane pressure exceeding a predefined level, an alarm signal can be generated.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: June 11, 2013
    Assignee: Nxstage Medical, Inc.
    Inventors: James M. Brugger, Jeffrey H. Burbank, Brian C. Green
  • Patent number: 8460228
    Abstract: A tubing set is disclosed including a first line having first and second ends, a bag spike at the first end configured for connection to a source of infusate, and a connector at the second end configured for connection to a blood line. The first line has a pumping portion for engagement with an infusate pump. The tubing set includes a second line having first and second ends, the first end being attached to the first line between the first line pumping portion and the first line second end and the second end being configured for connection to the first line between the first line first end and the first line pumping portion. The second line second end is configured for connection to the first line by a dual lumen spike.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: June 11, 2013
    Assignee: NxStage Medical Inc.
    Inventors: Jeffrey H. Burbank, Joseph Turk, Dennis M. Treu, R. Michael Hofmann, James M. Brugger
  • Publication number: 20130069778
    Abstract: An automatic locking system for a medical treatment device helps to ensure that an assistant is present during treatment of a patient. Among the features disclosed biometric authentication to verify that a trained assistant is present, a presence detector to ensure the assistant is continuously present during treatment, and warning and recovery processes that allow intermittent lapses in the continuous presence of the assistant.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 21, 2013
    Inventors: Jeffrey H. BURBANK, Dennis M. TREU, James M. BRUGGER
  • Publication number: 20130032537
    Abstract: Blood treatment system and method for high rate hemofiltration ensures against pyrogenic patient reaction by providing various mechanisms for filtering replacement fluid to remove endotoxins and other safety features including detecting incorrect fluid administration.
    Type: Application
    Filed: May 7, 2012
    Publication date: February 7, 2013
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Publication number: 20130012914
    Abstract: One or more waste balancing systems may be used in a fluid circulating system for medical use. The fluid circulating system may be part of a blood treatment system for a patient suffering renal failure. A waste balancing system may include a pressure element operable to maintain a constant fluid pressure created by the combined weight of waste removed from a patient and replacement fluid for providing to a patient. Multiple evaluation characteristics or control parameters may be evaluated or controlled for safety and accuracy. At least part of the waste balancing system may be incorporated into a disposable cartridge.
    Type: Application
    Filed: July 10, 2012
    Publication date: January 10, 2013
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Publication number: 20120325696
    Abstract: Systems, methods, and devices for preparation of water for various uses including blood treatment are described. In embodiments, fluid is passed either by pump or passively by gravity feed, through various filtration elements from a fluid source to a treatment fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment which provides multiple benefits and liabilities to overcome, as discussed herein. Mechanisms for preparing pure water for infusion or medicaments are described such as elimination of chlorine and colloidal aluminum. Also various control mechanisms to help avoid contamination are describe.
    Type: Application
    Filed: September 5, 2012
    Publication date: December 27, 2012
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. BURBANK, Brian C. GREEN, Dennis M. TREU, Christopher S. MCDOWELL, Goetz FRIEDERICHS
  • Publication number: 20120305481
    Abstract: A first connector of a connector assembly of a sterile batch container can be unsealed. The connector assembly can be attached to a filling port of the sterile batch container and can have a sterile filter arranged between the filling port and the first connector. The first connector can be coupled so as to receive produced purified water. A transmembrane pressure can be monitored across the sterile filter while flowing the purified water through the connector assembly into the sterile batch container so as to provide a sterile fluid stored therein. The connector assembly can be detached from the filling port of the sterile batch container. After the detaching, the sterile batch container can be coupled to the blood treatment system. In response to a change in the transmembrane pressure exceeding a predefined level, an alarm signal can be generated.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 6, 2012
    Inventors: JAMES M. BRUGGER, Jeffrey H. Burbank, Brian C. Green
  • Patent number: 8235931
    Abstract: One or more waste balancing systems may be used in a fluid circulating system for medical use. The fluid circulating system may be part of a blood treatment system for a patient suffering renal failure. A waste balancing system may include a pressure element operable to maintain a constant fluid pressure created by the combined weight of waste removed from a patient and replacement fluid for providing to a patient. Multiple evaluation characteristics or control parameters may be evaluated or controlled for safety and accuracy. At least part of the waste balancing system may be incorporated into a disposable cartridge.
    Type: Grant
    Filed: August 5, 2009
    Date of Patent: August 7, 2012
    Assignee: NxStage Medical, Inc.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Publication number: 20120194335
    Abstract: One of the most significant safety concerns in the automation of extracorporeal blood treatments such as dialysis is the risk of blood leakage. Extracorporeal blood treatment systems draw blood at such a high rate that a loss of integrity in the blood circuit can be serious. There are a number of mechanisms for detecting and preventing leaks, but none is perfect. This tends to limit the use of such equipment in unsupervised settings, such as the home will be limited. Some leak detection schemes can be made sensitive enough to detect the barest of leaks, but when this is done, they result in too many false positives. The invention combines information from multiple inputs to enhance sensitivity in leak detection and reduce the problem of false positives.
    Type: Application
    Filed: February 27, 2012
    Publication date: August 2, 2012
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Patent number: 8202420
    Abstract: A method and device for blood treatments that use fluids such as dialysate and replacement fluid for renal replacement therapy. In an embodiment, fluid is passed either by pump or passively by gravity feed, through a microporous sterilization filter from a fluid source to a replacement fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment. As a result, the sterilization filter can have a small capacity. In another embodiment, a filter is placed immediately prior to the point at which the sterile fluid is consumed by the treatment process. The latter may be used in combination with the former embodiment as a last-chance guarantee of sterility and/or that the fluid is free of air bubbles. It may also be used as the primary means of sterile-filtration.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: June 19, 2012
    Assignee: NxStage Medical, Inc.
    Inventors: James M. Brugger, Jeffrey H. Burbank, Brian C. Green
  • Patent number: 8192387
    Abstract: Blood treatment system and method for high rate hemofiltration ensures against pyrogenic patient reaction by providing various mechanisms for filtering replacement fluid to remove endotoxins and other safety features including detecting incorrect fluid administration.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: June 5, 2012
    Assignee: NxStage Medical, Inc.
    Inventors: James M. Brugger, Jeffrey H. Burbank
  • Patent number: 8042838
    Abstract: Devices can use various features to prevent the disconnection of connectors used in medical treatments. For example, a disconnection prevention member can have ends which hold luer connectors such that a male luer connector is prevented from separating from a female luer connector. The member can thus prevent disconnection of luer connectors that are incompletely mated.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: October 25, 2011
    Assignee: Nxstage Medical, Inc.
    Inventors: Kenneth Everett Buckler, David Farias De Souza, Jeffrey H. Burbank, James M. Brugger, William Weigel
  • Publication number: 20110240547
    Abstract: A method and device for blood treatments that use fluids such as dialysate and replacement fluid for renal replacement therapy. In an embodiment, fluid is passed either by pump or passively by gravity feed, through a microporous sterilization filter from a fluid source to a replacement fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment. As a result, the sterilization filter can have a small capacity. In another embodiment, a filter is placed immediately prior to the point at which the sterile fluid is consumed by the treatment process. The latter may be used in combination with the former embodiment as a last-chance guarantee of sterility and/or that the fluid is free of air bubbles. It may also be used as the primary means of sterile-filtration.
    Type: Application
    Filed: June 13, 2011
    Publication date: October 6, 2011
    Inventors: James M. Brugger, Jeffrey H. Burbank, Brian C. Green
  • Publication number: 20110186521
    Abstract: Systems, methods, and devices for preparation of water for various uses including blood treatment are described. In embodiments, fluid is passed either by pump or passively by gravity feed, through various filtration elements from a fluid source to a treatment fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment which provides multiple benefits and liabilities to overcome, as discussed herein. Mechanisms for preparing pure water for infusion or medicaments are described such as elimination of chlorine and colloidal aluminum. Also various control mechanisms to help avoid contamination are describe.
    Type: Application
    Filed: April 11, 2011
    Publication date: August 4, 2011
    Inventors: Jeffrey H. BURBANK, Brian C. GREEN, Dennis M. TREU, Christopher S. MCDOWELL, Goetz FRIEDERICHS